Kazuo Kimura

发表

The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial

N. Hagiwara, A. Hirayama, S. Yasuda, 2022, BMC Medicine.

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE Trial.

N. Hagiwara, A. Hirayama, S. Yasuda, 2021, JACC. Cardiovascular interventions.

More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.

M. Matsuzaki, T. Hiro, Takeshi Kimura, 2010, Journal of atherosclerosis and thrombosis.

Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories

N. Hagiwara, S. Yasuda, M. Ishii, 2022, JACC Asia.

Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2

Takeshi Kimura, Y. Morino, T. Morimoto, 2020, Cardiovascular Intervention and Therapeutics.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

M. Matsuzaki, A. Hirayama, T. Hiro, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction.

Y. Ozaki, K. Tanabe, K. Saku, 2022, Journal of cardiology.

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2013, Journal of the American College of Cardiology.

Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)

Y. Hayashi, T. Akasaka, K. Tanabe, 2012, Circulation.

Long-Term Clinical Outcomes After Filter Protection During Percutaneous Coronary Intervention in Patients With Attenuated Plaque

T. Kume, K. Tanabe, Y. Ikari, 2020 .

K. Kozuma, T. Isshiki, K. Hibi, 2018, JACC: Cardiovascular Interventions.

JCS 2018 Guideline on Revascularization of Stable Coronary Artery Disease.

F. Otsuka, T. Akasaka, S. Takanashi, 2022, Circulation journal : official journal of the Japanese Circulation Society.

Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease

N. Hagiwara, S. Yasuda, M. Ishii, 2023, Open Heart.

Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction A Landmark Sub-Analysis from J-MINUET Registry

K. Tanabe, Y. Ozaki, K. Saku, 2021 .

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.

N. Hagiwara, S. Yasuda, K. Kaikita, 2022, JAMA cardiology.

Shorter door-to-balloon time, better long-term clinical outcomes in ST-segment elevation myocardial infarction patients: J-MINUET Substudy.

K. Tanabe, K. Saku, S. Oshima, 2023, Journal of cardiology.

Study Protocol and Baseline Characteristics of Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, The Combination of a Randomized Control Trial and an Observational Biomarker Study.

H. Daida, Y. Ozaki, T. Murohara, 2022, American heart journal.

A case of a coronary covered stent for repeated restenosis at the anastomosis site between saphenous vein graft and graft prosthesis.

T. Ishikawa, T. Sugano, K. Tamura, 2021, Journal of cardiology cases.

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis

N. Hagiwara, S. Yasuda, K. Kaikita, 2022, Journal of the American Heart Association.

Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2017, Journal of cardiology.

Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial

T. Akasaka, K. Tanabe, Takeshi Kimura, 2015, Circulation. Cardiovascular interventions.

Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial).

T. Akasaka, K. Tanabe, Takeshi Kimura, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Progression of coronary atherosclerosis: is coronary spasm related to progression?

M. Nobuyoshi, H. Yokoi, K. Kimura, 1991, Journal of the American College of Cardiology.

Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant.

T. Nakamura, M. Nobuyoshi, Y. Nakagawa, 1992, American Heart Journal.

Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.

K. Tanabe, Y. Ozaki, K. Saku, 2021, International heart journal.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease

T. Hiro, S. Hokimoto, Y. Nakagawa, 2024, Journal of Clinical Lipidology.

Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.

T. Akasaka, K. Tanabe, Takeshi Kimura, 2015, European heart journal cardiovascular Imaging.